Home

CM-slider-logo-2x

Checkmate Capital is an investment group managing family office assets and Asian-Pacific institutional funds. Checkmate's primary areas of investment are energy and energy technology, biomedical and biotechnology, and diversified special situations opportunities.

With offices in Los Angeles, Beijing and an affiliate office in Singapore, Checkmate's investment partners provide seasoned and diverse expertise in their relevant industries and leverage a powerfully efficient international ecosystem of strategic partners, business talent and resources.

Typically, long-term focused, Checkmate's investment approach embodies strategic oversight and an ownership paradigm. Where most investment funds end is where our applied expertise in management and strategic acceleration begins.

OUR APPROACH

Checkmate Capital combines strong portfolio infrastructure with internal industry leadership to create or advance special situation investment opportunities and alliances that can be enhanced using strategic aspects of the Checkmate platform.

With a longer-term focus than typical investment groups, our active-partner approach generates attractive returns over an extended time horizon.

OUR EXPERTISE

Utilizing the Checkmate Approach will enable our investors (and the companies in which we invest) to leverage multiple synergies and complementary relationships across Checkmate’s technology spectrum.

Checkmate’s equity acquisition strategy provides for downside protection, risk mitigation and upside potential.

STRUCTURED
FINANCING

Super-Senior and Senior Debt Financing
Preferred Equity Instrument Financing
Mezzanine & Bridge Financing
Tax Credit Financing
Hybrid Securities
Factoring

PRIVATE EQUITY
SECONDARY MARKET

Structured Joint Ventures
Securitization
Stapled Secondaries
Synthetic Secondaries
Tail-End
Secondary Direct
Structured Secondary

EQUITY
ACQUISITION

Growth Capital
Venture Capital
Distressed Assets
Special Situations
Leveraged Buy-Outs

OUR PORTFOLIO

energy
lifesciences
biomed
energytech
ag-EN
healthcare
biotech

FEATURED PRESS

BioTech & BioMedical
Checkmate invests in Tela Bio
Energy Technology
Checkmate invests in Site Fuel
Global Industry Conferences
Checkmate Sponsorship and Support
BioTech & BioMedical
Checkmate invests in Tela Bio

TELA Bio Announces Series B Investment by Checkmate Capital

Surgical reconstruction company looks to forge long-term relationship with strategic investment group.

MALVERN, PA – April 16, 2018 – TELA Bio®, Inc., a surgical reconstruction company leading the development and commercialization of OviTex® Reinforced BioScaffolds (RBSs) for soft tissue repair, today announced that Checkmate Capital, a strategic investment group based in Los Angeles, California and Beijing, China, has agreed to an initial Series B investment in TELA Bio.

“Given our historic and specific interest in cutting-edge biotech and biomedical technology, we are particularly enthusiastic about the scientific and commercial advances TELA Bio continues to achieve,” said Checkmate Managing Director/Partner Tom Paschall. “The company’s vision and progress represent ideals that are consistent with Checkmate’s objective of supporting best-of-breed technologies and this investment reflects our belief in TELA Bio’s impressive success story and continuing growth opportunity which we plan to further help accelerate into the future.”

TELA Bio first commercialized OviTex RBSs in July 2016. They are a distinct class of surgical implants that integrate biologic and synthetic materials in a unique embroidered construction that allows free movement of fluid and cells through the construct. Over 1,800 implantations have been completed to-date in a wide range of hernia procedures using a variety of surgical techniques.

“We are pleased to announce the investment by Checkmate Capital as we continue our mission to improve patient care and surgical outcomes while reducing costs,” said Antony Koblish, president and CEO of TELA Bio. “We look forward to scaling this initial investment as we forge a long-term relationship in which we prove to be an innovative partner focused on delivering clinical and financial value.”

In March 2018, TELA Bio announced that data from a retrospective study evaluating the use of OviTex RBSs in abdominal wall reconstruction (AWR) procedures showed low recurrence and complication rates. The company has initiated a post-market clinical study, BioScaffold Reconstruction of Abdominal wall and Ventral hernia defects with Open or laparoscopic repair (BRAVO).

About Checkmate Capital

Checkmate Capital is an investment group managing family office assets and Asian-Pacific institutional funds. Checkmate's primary areas of investment are biomedical and biotechnology, energy and energy technology, and diversified special situations opportunities. With offices in Los Angeles, Beijing and an affiliate office in Singapore, Checkmate's investment partners provide seasoned and diverse expertise in their relevant industries and leverage a powerfully efficient international ecosystem of strategic partners, business talent and resources. Typically long-term focused, Checkmate's investment approach embodies strategic oversight and an ownership paradigm.

About TELA Bio, Inc.

TELA Bio, Inc. is a privately-owned company focused on bringing innovative, cost-effective, surgical reconstruction solutions to surgeons, hospitals and patients. The company's OviTex Reinforced BioScaffolds (RBSs) products, designed for hernia repair and abdominal wall reconstruction procedures, integrate polymer and biologic materials in a uniquely embroidered construction using novel engineering design principles. The OviTex portfolio is supported by high-quality, data-driven science and extensive pre-clinical research that has consistently demonstrated the advantages of an RBS over commercially available products. OviTex RBSs are commercially available in the U.S., and TELA Bio plans to launch OviTex RBSs in the European Union. The company is collaborating with leading surgeons to drive rapid product development and establish TELA Bio as a leader in surgical reconstruction. To learn more about TELA Bio visit http://www.telabio.com.

About OviTex Reinforced BioScaffolds

OviTex Reinforced BioScaffolds (RBSs) are intended for use as a surgical mesh to reinforce and/or repair soft tissue where weakness exists. Indications for use include the repair of hernias and/or abdominal wall defects that require the use of reinforcing or bridging material to obtain the desired surgical outcome.

Do not use OviTex RBSs in patients known to be sensitive to materials of ovine (sheep) origin. For additional important safety information, please see the OviTex RBSs Instructions for Use.

The statements made or results achieved by TELA Bio customers described herein were achieved in their specific setting. Due to variations in clinical experience and technique, there is no guarantee that these results are typical. Bench testing may not be indicative of clinical performance.

Caution: Federal (US) law restricts this device to sale by or on order of a physician.

TELA Bio, Inc. owns or has applied for the following trademarks or service marks: OviTex, TELA Bio.

Energy Technology
Checkmate invests in Site Fuel

Site Fuel Announces $5 Million Series A Financing by Checkmate Capital

April 24, 2018 / Newport Beach, CA

Site Fuel, Inc., the creator of the only nationwide digital fuel exchange, connecting suppliers, buyers, and 3rd party haulers, announced today that it has completed a $5 million Series A financing. The company will use the funds to accelerate its rapid growth, scale its technology service, pursue strategic partnerships, and expand its team. Site Fuel connects thousands of fuel suppliers and independent haulers with businesses and government agencies who need to buy fuel via its exchange marketplace; in 2017, the company grew its business by more than 450%.

The financing was led by Checkmate Capital, a strategic investment group which will be a long term capital and technology partner to Site Fuel and join the Site Fuel Board. Checkmate is acquiring 25% of Site Fuel including 10% already funded and an additional 15% staged over the next several months.

“Our goal has always been to build a service that seamlessly connects the players in the fuel market: Buyers, suppliers, and 3rd party hauling services all come together on the Site Fuel exchange. We provide the only integrated service that combines real-time visibility into nationwide fuel pricing with complete transparency around the delivery process – or what is often referred to as “the last mile”,” said Brandon Huff, COO & CTO of Site Fuel. “We’re thrilled to have such world-class, visionary investors joining forces with us.”

“We are delighted to have provided this financing and believe Site Fuel has the potential to become an iconic technology company,” said Tom Paschall, Partner/Director at Checkmate Capital. “Site Fuel brings proven profitability with industry-leading and sophisticated yet user-friendly technology to a fragmented industry at lower cost. The management team’s focus on enhanced functionality of their exchange and app-based technology platform is both visionary and pragmatic, and Site Fuel's operations have many touch points within Checkmate's networks in the energy, construction, technology and ag-tech sectors where we can help maximize mutual opportunities in the future.”

About Site Fuel

The mission of Site Fuel is to simplify the fuel delivery process for all parties involved; by creating the world’s first digital fuel exchange marketplace, Site Fuel automates the entire process – from supplier selection and delivery to automated drop ticket and invoice creation.  The company’s service has been used on projects in all 50 states and in some of the largest construction projects in the world.  Site Fuel was founded in Newport Beach, CA in 2015, and has offices located in Charleston, SC, and Pune, India.

About Checkmate Capital

Checkmate Capital is an investment group managing family office assets and Asian-Pacific institutional funds. Checkmate's primary areas of investment are energy and energy technology, biomedical and biotechnology, and diversified special situations opportunities. With offices in Los Angeles, Beijing and an affiliate office in Singapore, Checkmate's investment partners provide seasoned and diverse expertise in their relevant industries and leverage a powerfully efficient international ecosystem of strategic partners, business talent and resources. Typically, long-term focused, Checkmate's investment approach embodies strategic oversight and an ownership paradigm.

Global Industry Conferences
Checkmate Sponsorship and Support

Checkmate Capital is a proud Gold Sponsor of the Beijing UGlobal Investment Opportunities Forum

May 8, 2018 / Beijing, China

Checkmate Capital as a Gold Sponsor is proud to support UGlobal, formerly The China Investor, and its return to China for its fourth Investment Opportunities Forum.

The Investment Opportunities Forum connects as a platform of robust discussion on global private equity investment trends – both outbound from China into North America and inbound into China.

In addition to a highlighted showcase and booth presence at the conference, Tom Paschall, Managing Partner of Checkmate Capital, will also be a featured panelist sharing his thesis and insights on trends in technology investing.

Visit https://www.uglobal.com/en/investment/conference/2018-beijing-global-investment-forum/ for more details and registration to be an attending guest of Checkmate Capital.

About UGlobal

The UGlobal Investment Opportunities Forum aims to connect Chinese financial institutions and institutional investors to global private equity opportunities and to facilitate connections between industry professionals to strengthen overseas partnerships.

We welcome global family offices, wealth managers, financial groups and other stakeholders to the Rosewood Beijing for a two-day networking and educational event.

At our last forum in November 2017, more than 400 attendees gathered to build business partnerships and gain exclusive investment knowledge via advanced and beginner level panels.

About Checkmate Capital

Checkmate Capital is an investment group managing family office assets and Asian-Pacific institutional funds. Checkmate's primary areas of investment are energy and energy technology, biomedical and biotechnology, and diversified special situations opportunities.

With offices in Los Angeles, Beijing and an affiliate office in Singapore, Checkmate's investment partners provide seasoned and diverse expertise in their relevant industries and leverage a powerfully efficient international ecosystem of strategic partners, business talent and resources.

footer-logo-2x

contact@checkmate.capital

  • Los Angeles
  • Beijing
  • Singapore

2018 © Checkmate Capital. All rights reserved.